Logo of Advanced Oxygen Therapy, Inc. - Oxygen Wound Therapy
  • Solutions
    • NEXA™ NPWT System
      • NEXA™ Overview
      • NEXA™ Advantage
      • NEXA™ Innovations
      • NEXA™ Resources
    • Topical Wound Oxygen (TWO2)
      • TWO2 Extremity Chamber
      • TWO2 Multi-Patch
    • Instructions for Use
      • USA
        • TWO2 – English
        • TWO2 – Spanish
        • NEXA – English
      • International
        • TWO2
        • NEXA
  • Healthcare Professionals
    • TWO2 Extremity Chamber
    • Multi-Patch
    • AOTI – Your Care Partner
    • FAQs
    • Education
  • Patients
    • Extremity Chamber
    • Multi-Patch
    • Patient Videos
    • FAQs
  • Clinical Evidence
    • Featured
    • Browse by Category
    • Levels of Evidence
    • Scientific Clinical Advisory Board
  • About
    • Partnerships
    • Core Values
    • Certifications
    • Management Team
    • Scientific Clinical Advisory Board
    • Events
    • In the News
    • Careers
  • Investors
    • Regulatory News
    • Corporate Governance
    • Share Price Information
    • Financial Reports & Publications
    • Shareholders
    • Contacts and Advisors
    • Board of Directors
    • Email Alerts
    • AIM Rule 26
  • Contact Us
Cost Effectiveness of Topical Wound Oxygen Therapy for Chronic Diabetic Foot Ulcers

Cost Effectiveness of Topical Wound Oxygen Therapy for Chronic Diabetic Foot Ulcers

by Mary Anne Brigham | Apr 29, 2025 | In The News

AOTI’s Dr. Mike Griffiths on Breakthrough for Diabetic Foot Ulcers and Chronic Wound Care

AOTI’s Dr. Mike Griffiths on Breakthrough for Diabetic Foot Ulcers and Chronic Wound Care

by Mary Anne Brigham | Feb 10, 2025 | In The News

AOTI wins the Best Newcomer Award at the AIM Awards 2024

AOTI wins the Best Newcomer Award at the AIM Awards 2024

by Darron Daly | Oct 10, 2024 | In The News

London Stock Exchange welcomes AOTI, Inc. celebrating its successful listing on AIM

London Stock Exchange welcomes AOTI, Inc. celebrating its successful listing on AIM

by Mike Hughes | Aug 19, 2024 | In The News

AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population

AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population

by Mike Hughes | Mar 23, 2022 | In The News, Press

OCEANSIDE, Calif., March 23, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the global leader in noninvasive topical oxygen wound healing solutions, announced today that is has received Chinese National Medical Products Administration (NMPA), commonly...
AOTI Receives China FDA Approval for Topical Wound Oxygen (TWO2) Therapy Providing Renewed Hope for World’s Largest Diabetic Foot Ulcer Population

Announcing Key Leadership Team Additions and Scientific Clinical Advisory Board Formation

by Mike Hughes | Feb 14, 2022 | In The News, Press

OCEANSIDE, Calif., Feb. 14, 2022 /PRNewswire/ — Advanced Oxygen Therapy Inc. (AOTI), the leader in noninvasive sustained wound healing solutions, announced today a number of significant additions to its Leadership Team, bringing to the company over 100 years of...
Page 1 of 212»
  • Products
  • Healthcare Professionals
  • Professional FAQ
  • Clinical Evidence
  • About Us
  • Careers
  • Contact Us

ABOUT AOTI

We help people with chronic conditions get back to living their lives to the fullest. Advancing health equity to care, improving clinical outcomes and quality of life, and advancing health equity. 

Connect with Us

MENU

Products

Healthcare Professionals

Patients

Clinical Evidence

About

Careers

Investors

Contact Us

Partnerships

CONTACT

1-866-HEAL-TWO

GENERAL INQUIRIES

customersupport@aotinc.net

CLINICAL SUPPORT

clinicalsupport@aotinc.net

  • Follow
  • Follow
  • Follow

Copyright ©2025, All Rights Reserved

Designed by MRB Media

  • Cookie Policy
  • Patents
  • Privacy Policy
  • SMS Texting Privacy Policy
  • Regulatory
  • Terms of Service

Copyright ©2025, All Rights Reserved

Designed by MRB Media

  • Cookie Policy
  • Patents
  • Privacy Policy
  • SMS Texting Privacy Policy
  • Regulatory
  • Terms of Service